The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Spain in focus after bailout rumours

Fri, 08th Jun 2012 16:37

- Spanish bailout could be on the cards- Fitch downgrades Spain to BBB- Investors look ahead of Chinese data this weekendRumours about an imminent recapitalisation of Spain's banking sector and concerns over global growth were doing the rounds on Friday, yet the Footsie still managed to pare losses by the close.According to a Financial Times article this afternoon, Spain may ask for bailout aid for its financial sector as early as tomorrow during a conference call with European finance ministers.Fitch Ratings said last night that the "likely 'fiscal cost'" of restructuring and recapitalising the Spanish banking sector would be between €60bn and €100bn in a worst-case scenario. This came as the ratings agency downgraded its sovereign debt rating for the country from A to BBB. Also weighing on sentiment today were yesterday's comments from Federal Reserve Chairman Ben Bernanke who "performed his usual trick of depressing the markets", according to Craig Erlam from Alpari. Analysts were hoping for hints of imminent stimulus measures but Bernanke failed to say whether the Fed would be embarking on QE3 any time soon. "The positive sentiment from earlier in the week has been knocked over the last 24 hours. With the ECB, BOE and Fed all deciding against further QE or rate cuts this week, it's surprising that the markets have held up as well as they have," Erlam said in an emailed note.This afternoon, President Barack Obama said that the ongoing crisis in Europe could have a "potential impact" on the US economy as he urged Eurozone leaders to act: "The sooner they act the more decisive and concrete their action, the sooner people and markets will regain some confidence."Investors will still be digesting the recent interest rate cut from China, which initially spurred impressive gains for equity markets on Thursday. However, ahead of some key inflation and industrial production figures due out this weekend from the world's second-largest economy, some analysts are questioning whether the rate cut was a pre-emptive move ahead of what could be some disappointing data. FTSE 100: Miners down, defensives upVedanta, Kazakhmys, Antofagasta, Xstrata, Rio Tinto, Glencore and ENRC were among the worst performers of the day as investors fled from risk. BHP Billiton was also among the fallers after Bank of America Merrill-Lynch reduced its profit forecasts for the group on the back of lower oil prices estimates. Kazakhmys announced late on that it has signed an agreement with JSC RusHydro, one of Russia's largest power generating companies, to consider establishing a hydro-electric power joint venture. The defensive utilities sector benefited from its 'safe-haven' appeal today with Severn Trent, Centrica, United Utilities, SSE and National Grid making gains. Credit Suisse raised its target price for National Grid today after saying that Ofgem's new RIIO regulation presents a £2.5bn opportunity for the group.Capita was a strong performer after JP Morgan Cazenove reiterated its overweight rating on the outsourcing giant.Pharmaceuticals leviathan GlaxoSmithkline was also in demand after extending the offer period for its hostile take-over of US sector peer Human Genome Sciences (HGS) by a further three weeks.FTSE 250: Bumi leaps on mining contractMining firm Bumi leapt into the top spot on the second-tier index after reportedly signing a contract to sell 50m metric tons of coal. According to Dow Jones Newswires, the coal will be sold at an average price of $80 per ton this calendar year. The firm's Resource Director, Dileep Srivastava, was quoted as saying: "The sales contract is 67% of our 75-million-ton output guidance for 2012." Heading the other way was energy markets-focused engineer Lamprell which was battered after sneaking out a profit warning on Thursday after the London market closed, saying that it now expects to make a half-year loss of between $15m and $20m, compared with earlier guidance of "a small loss". The group also said that Chairman Jonathan Silver would step down. "We continue to believe that management's credibility has fundamentally deteriorated," Nomura said in a research note this morning.FTSE 100 - RisersCapita (CPI) 649.50p +2.85%Severn Trent (SVT) 1,782.00p +2.71%Centrica (CNA) 315.20p +2.20%British Sky Broadcasting Group (BSY) 696.00p +2.20%Standard Life (SL.) 220.40p +1.90%United Utilities Group (UU.) 680.50p +1.80%Vodafone Group (VOD) 171.50p +1.51%Shire Plc (SHP) 1,879.00p +1.51%Kingfisher (KGF) 279.00p +1.31%Reed Elsevier (REL) 493.40p +1.31%FTSE 100 - FallersVedanta Resources (VED) 935.50p -5.07%Rio Tinto (RIO) 2,869.00p -4.84%Eurasian Natural Resources Corp. (ENRC) 423.80p -3.94%Evraz (EVR) 279.20p -3.19%Kazakhmys (KAZ) 705.00p -3.16%BHP Billiton (BLT) 1,767.00p -2.91%Anglo American (AAL) 2,074.00p -2.77%Petrofac Ltd. (PFC) 1,535.00p -2.66%Schroders (Non-Voting) (SDRC) 976.00p -2.59%Antofagasta (ANTO) 1,060.00p -2.21%FTSE 250 - RisersBumi (BUMI) 365.00p +11.93%Atkins (WS) (ATK) 694.50p +6.27%New World Resources A Shares (NWR) 326.10p +4.19%Bellway (BWY) 770.50p +3.56%Ophir Energy (OPHR) 615.00p +3.36%Grainger (GRI) 90.00p +2.97%Synergy Health (SYR) 887.00p +2.60%RPS Group (RPS) 202.00p +2.54%Bovis Homes Group (BVS) 432.30p +2.32%Brown (N.) Group (BWNG) 233.60p +1.96%FTSE 250 - FallersLamprell (LAM) 84.50p -22.26%Kesa Electricals (KESA) 49.81p -7.93%Afren (AFR) 108.40p -7.51%Lonmin (LMI) 747.50p -5.62%Essar Energy (ESSR) 117.40p -5.55%Anglo Pacific Group (APF) 238.80p -5.50%Ocado Group (OCDO) 94.90p -5.10%Imagination Technologies Group (IMG) 487.80p -4.17%Avocet Mining (AVM) 157.00p -3.98%Hays (HAS) 72.25p -3.73%BC
More News
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.